These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12450697)

  • 1. A randomized, placebo-controlled trial of subcutaneous administration of GM-CSF as a vaccine adjuvant: effect on cellular and humoral immune responses.
    Somani J; Lonial S; Rosenthal H; Resnick S; Kakhniashvili I; Waller EK
    Vaccine; 2002 Dec; 21(3-4):221-30. PubMed ID: 12450697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines.
    Disis ML; Bernhard H; Shiota FM; Hand SL; Gralow JR; Huseby ES; Gillis S; Cheever MA
    Blood; 1996 Jul; 88(1):202-10. PubMed ID: 8704175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GM-CSF improves the immune response to the diphtheria-component in a multivalent vaccine.
    Grasse M; Meryk A; Miggitsch C; Grubeck-Loebenstein B
    Vaccine; 2018 Jul; 36(31):4672-4680. PubMed ID: 29961602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hib antibody responses in infants following diphtheria, tetanus, acellular pertussis, and conjugated Haemophilus influenzae type b (Hib) combination vaccines with decreasing amounts of tetanus toxoid.
    Bernstein HH; Seyferth ER
    Vaccine; 2017 Dec; 35(48 Pt B):6707-6711. PubMed ID: 29054729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
    Evans TG; Schiff M; Graves B; Agosti J; Barritt ML; Garner D; Holley JL
    Clin Nephrol; 2000 Aug; 54(2):138-42. PubMed ID: 10968690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood dendritic cells and GM-CSF as an adjuvant for hepatitis B vaccination in hemodialysis patients.
    Verkade MA; van de Wetering J; Klepper M; Vaessen LM; Weimar W; Betjes MG
    Kidney Int; 2004 Aug; 66(2):614-21. PubMed ID: 15253714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant.
    Yağci M; Acar K; Sucak GT; Yamaç K; Haznedar R
    Eur J Haematol; 2007 Oct; 79(4):292-6. PubMed ID: 17655695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with recombinant human granulocyte-macrophage colony-stimulating factor as a vaccine adjuvant elicits both a cellular and humoral response to recombinant human granulocyte-macrophage colony-stimulating factor.
    McNeel DG; Schiffman K; Disis ML
    Blood; 1999 Apr; 93(8):2653-9. PubMed ID: 10194445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of influenza vaccine with granulocyte-macrophage colony-stimulating factor or placebo in cancer patients.
    Ramanathan RK; Potter DM; Belani CP; Jacobs SA; Gravenstein S; Lim F; Kim H; Savona S; Evans T; Buchbarker D; Simon MB; Depee JK; Trump DL
    J Clin Oncol; 2002 Nov; 20(21):4313-8. PubMed ID: 12409329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.
    Wang X; Dong A; Xiao J; Zhou X; Mi H; Xu H; Zhang J; Wang B
    Cell Mol Immunol; 2016 Nov; 13(6):850-861. PubMed ID: 26166767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of GM-CSF and IL-5 as molecular adjuvants on immune responses and contraception induced by mZP3 DNA vaccination.
    Ma X; Kadir Z; Li J; Zhang F
    Am J Reprod Immunol; 2012 Dec; 68(6):476-85. PubMed ID: 22934542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte macrophage colony-stimulating factor as an adjuvant for hepatitis B vaccination: a meta-analysis.
    Cruciani M; Mengoli C; Serpelloni G; Mazzi R; Bosco O; Malena M
    Vaccine; 2007 Jan; 25(4):709-18. PubMed ID: 16963165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte-macrophage colony-stimulating factor as an adjuvant to hepatitis B vaccination in maintenance hemodialysis patients.
    Anandh U; Bastani B; Ballal S
    Am J Nephrol; 2000; 20(1):53-6. PubMed ID: 10644869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral immune response to tetanus-diphtheria vaccine given during extended use of chloroquine or primaquine malaria chemoprophylaxis.
    Fryauff DJ; Cryz SJ; Widjaja H; Mouzin E; Church LW; Sutamihardja MA; Richards AL; Subianto B; Hoffman SL
    J Infect Dis; 1998 Jun; 177(6):1762-5. PubMed ID: 9607867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220.
    Overton ET; Kang M; Peters MG; Umbleja T; Alston-Smith BL; Bastow B; Demarco-Shaw D; Koziel MJ; Mong-Kryspin L; Sprenger HL; Yu JY; Aberg JA
    Vaccine; 2010 Aug; 28(34):5597-604. PubMed ID: 20600512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression and modulation of cellular and humoral immune responses to Haemophilus influenzae type B (Hib) conjugate vaccine in hib-diphtheria-tetanus toxoids-acellular pertussis combination vaccines: a study in a rat model.
    Mawas F; Newman G; Burns S; Corbel MJ
    J Infect Dis; 2005 Jan; 191(1):58-64. PubMed ID: 15593004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A non-living nasal influenza vaccine can induce major humoral and cellular immune responses in humans without the need for adjuvants.
    Samdal HH; Bakke H; Oftung F; Holst J; Haugen IL; Korsvold GE; Kristoffersen AC; Krogh G; Nord K; Rappuoli R; Berstad AK; Haneberg B
    Hum Vaccin; 2005; 1(2):85-90. PubMed ID: 17038826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B immunization of healthy elderly adults: relationship between naïve CD4+ T cells and primary immune response and evaluation of GM-CSF as an adjuvant.
    Looney RJ; Hasan MS; Coffin D; Campbell D; Falsey AR; Kolassa J; Agosti JM; Abraham GN; Evans TG
    J Clin Immunol; 2001 Jan; 21(1):30-6. PubMed ID: 11321236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coadministration of Recombinant Adenovirus Expressing GM-CSF with Inactivated H5N1 Avian Influenza Vaccine Increased the Immune Responses and Protective Efficacy Against a Wild Bird Source of H5N1 Challenge.
    Wang X; Wang X; Jia Y; Wang C; Tang Q; Han Q; Xiao S; Yang Z
    J Interferon Cytokine Res; 2017 Oct; 37(10):467-473. PubMed ID: 29028432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-administration of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the immune response to antigens contained in infant vaccines routinely used in the United States.
    Marshall GS; Marchant CD; Blatter M; Friedland LR; Aris E; Miller JM
    Hum Vaccin; 2011 Feb; 7(2):258-64. PubMed ID: 21307655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.